Arcellx (ACLX) Non-Current Assets (2021 - 2025)

Arcellx's (ACLX) quarterly Non-Current Assets came in at $141.8 million in Q4 2025, up 26.59% year-on-year from $112.0 million in Q4 2024, and down 22.86% quarter-over-quarter from $183.8 million in Q3 2025.

Arcellx (ACLX) Non-Current Assets (2021 - 2025) Analysis & Trends

Arcellx's Non-Current Assets history runs 5 years deep, the most recent figure standing at $141.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 26.59% year-over-year to $141.8 million in Q4 2025; TTM through Dec 2025 was $574.8 million, a 16.06% decrease from a year earlier, with the FY2025 full-year figure at $141.8 million, up 26.59% from the prior year.
  • Non-Current Assets retreated to $141.8 million in Q4 2025 per ACLX's latest filing, from $183.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $204.1 million in Q2 2024 and bottomed at $16.0 million in Q4 2021.
  • The 5-year median for Non-Current Assets is $108.8 million (2023), against an average of $105.3 million.
  • Across the five-year window, Non-Current Assets surged 270.25% in 2024 and tumbled 50.81% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $16.0 million in 2021, then soared by 193.96% to $47.0 million in 2022, then jumped by 131.65% to $108.8 million in 2023, then rose by 2.99% to $112.0 million in 2024, then advanced by 26.59% to $141.8 million in 2025.
  • Per Business Quant, the three latest ACLX Non-Current Assets figures stand at $141.8 million (Q4 2025), $183.8 million (Q3 2025), and $155.2 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 141.81 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 141.81 Mn
Sep 30, 2025 183.84 Mn
Jun 30, 2025 155.19 Mn
Mar 31, 2025 93.93 Mn
Dec 31, 2024 112.02 Mn
Sep 30, 2024 177.61 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 190.96 Mn
Dec 31, 2023 108.77 Mn
Sep 30, 2023 122.76 Mn
Jun 30, 2023 65.46 Mn
Mar 31, 2023 51.58 Mn
Dec 31, 2022 46.95 Mn
Sep 30, 2022 47.02 Mn
Jun 30, 2022 49.58 Mn
Mar 31, 2022 22.60 Mn
Dec 31, 2021 15.97 Mn